-
EP3411018
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3411018
| EP3411018 - GALENIC FORMULATIONS OF ORGANIC COMPOUNDS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 13.11.2020 Database last updated on 13.11.2024 | |
| Former | Request for examination was made Status updated on 09.11.2018 | ||
| Former | The international publication has been made Status updated on 11.08.2017 | ||
| Former | unknown Status updated on 15.02.2017 | Most recent event Tooltip | 29.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2018/50] | Inventor(s) | 01 /
WINZENBURG, Gesine c/o Novartis Pharma AG Postfach 4002 Basel / CH | 02 /
TRUEBY, Bernd c/o Novartis Pharma AG Postfach 4002 Basel / CH | 03 /
CHEN, Fabian c/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080 / US | 04 /
AYALASOMAYAJULA, Surya Prakash c/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080 / US | 05 /
BUSH, Christopher c/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080 / US | 06 /
BERKHIN, Masha c/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080 / US | [2018/50] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2018/50] | Larbig, Karen Dorothee Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 17703476.6 | 02.02.2017 | [2018/50] | WO2017IB50569 | Priority number, date | EP20160154153 | 03.02.2016 Original published format: EP 16154153 | US201662293005P | 09.02.2016 Original published format: US 201662293005 P | [2018/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017134597 | Date: | 10.08.2017 | Language: | EN | [2017/32] | Type: | A1 Application with search report | No.: | EP3411018 | Date: | 12.12.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.08.2017 takes the place of the publication of the European patent application. | [2018/50] | Search report(s) | International search report - published on: | EP | 10.08.2017 | Classification | IPC: | A61K9/20, A61K9/28, A61K9/48, A61K31/216, A61K31/41 | [2018/50] | CPC: |
A61K31/41 (EP,IL,KR,US);
A61K9/4808 (EP,IL,KR,US);
A61K9/2846 (EP,IL,KR,US);
A61K31/216 (EP,IL,US);
A61K31/225 (EP,IL,KR,US);
A61K45/06 (EP,IL,US);
A61K9/2013 (IL,KR);
A61K9/2054 (EP,IL,KR,US);
A61K9/282 (IL,KR);
A61P9/00 (EP,IL,US);
A61P9/04 (IL,KR);
A61K2300/00 (IL,KR);
Y02A50/30 (EP)
(-)
| C-Set: |
A61K31/225, A61K2300/00 (US,EP);
A61K31/41, A61K2300/00 (EP,US) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/50] | Title | German: | GALENISCHE FORMULIERUNGEN ORGANISCHER VERBINDUNGEN | [2018/50] | English: | GALENIC FORMULATIONS OF ORGANIC COMPOUNDS | [2018/50] | French: | FORMES PHARMACEUTIQUES À BASE DE COMPOSÉS ORGANIQUES | [2018/50] | Entry into regional phase | 03.09.2018 | National basic fee paid | 03.09.2018 | Designation fee(s) paid | 03.09.2018 | Examination fee paid | Examination procedure | 31.08.2018 | Amendment by applicant (claims and/or description) | 03.09.2018 | Examination requested [2018/50] | 03.09.2018 | Date on which the examining division has become responsible | 12.11.2020 | Despatch of a communication from the examining division (Time limit: M06) | 27.08.2021 | Reply to a communication from the examining division | 31.03.2023 | Despatch of a communication from the examining division (Time limit: M06) | 31.10.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 10.01.2024 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 10.01.2024 | Request for further processing filed | 10.01.2024 | Full payment received (date of receipt of payment) Request granted | 18.01.2024 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 27.08.2021 | Request for further processing filed | 27.08.2021 | Full payment received (date of receipt of payment) Request granted | 08.09.2021 | Decision despatched | Fees paid | Renewal fee | 13.02.2019 | Renewal fee patent year 03 | 13.02.2020 | Renewal fee patent year 04 | 12.02.2021 | Renewal fee patent year 05 | 28.01.2022 | Renewal fee patent year 06 | 30.01.2023 | Renewal fee patent year 07 | 29.01.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2009061713 (NOVARTIS AG [CH], et al); | by applicant | EP0443983 | US5217996 | US5399578 | WO03059345 | WO2007056546 | WO2009061713 | WO2010086312 | WO2012027237 | WO2014029848 | WO2015030711 | WO2015028941 |